Constitutive	O
nuclear	B-protein
NF-kappa	I-protein
B	I-protein
in	O
cells	O
of	O
the	O
monocyte	O
lineage	O
.	O

In	O
monocytes	B-cell_type
,	O
the	O
nuclear	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
has	O
been	O
invoked	O
as	O
an	O
important	O
transcription	B-protein
factor	I-protein
in	O
the	O
expression	O
of	O
cytokine	B-DNA
genes	I-DNA
,	O
of	O
cell-surface	B-protein
receptors	I-protein
and	O
in	O
the	O
expression	O
of	O
human	O
immunodeficiency	O
virus	O
.	O

In	O
such	O
cells	O
,	O
DNA	O
binding	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
can	O
be	O
detected	O
without	O
intentional	O
stimulation	O
.	O

In	O
our	O
studies	O
,	O
cells	O
of	O
the	O
human	B-cell_line
monocytic	I-cell_line
line	I-cell_line
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
,	O
cultured	O
in	O
medium	O
containing	O
fetal-calf	O
serum	O
and	O
low	O
levels	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
also	O
exhibit	O
such	O
'constitutive	O
'	O
NF-kappa	B-protein
B	I-protein
,	O
as	O
demonstrated	O
by	O
mobility-shift	O
analysis	O
of	O
nuclear	O
extracts	O
.	O

This	O
nuclear	B-protein
NF-kappa	I-protein
B	I-protein
was	O
still	O
present	O
when	O
contaminant	O
LPS	O
was	O
removed	O
by	O
ultrafiltration	O
and	O
when	O
serum	O
was	O
omitted	O
.	O

Protein-DNA	O
complexes	O
of	O
constitutive	O
NF-kappa	B-protein
B	I-protein
are	O
similar	O
in	O
mobility	O
to	O
the	O
LPS-induced	B-protein
NF-kappa	I-protein
B	I-protein
and	O
both	O
are	O
recognized	O
by	O
an	O
antibody	O
specific	O
to	O
the	O
p50	B-protein
subunit	I-protein
of	O
NF-kappa	B-protein
B	I-protein
.	O

By	O
contrast	O
,	O
treatment	O
of	O
cells	O
with	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
will	O
only	O
block	O
LPS-induced	B-protein
NF-kappa	I-protein
B	I-protein
,	O
but	O
not	O
the	O
constitutive	B-protein
binding	I-protein
protein	I-protein
.	O

Using	O
LPS-free	O
and	O
serum-free	O
conditions	O
,	O
constitutive	O
NF-kappa	B-protein
B	I-protein
can	O
be	O
detected	O
in	O
different	O
cell	B-cell_line
lines	I-cell_line
of	O
the	O
monocytic	B-cell_type
lineage	I-cell_type
(	O
HL60	B-cell_line
,	O
U937	B-cell_line
,	O
THP-1	B-cell_line
,	O
Mono	B-cell_line
Mac	I-cell_line
1	I-cell_line
and	O
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
)	O
,	O
but	O
not	O
in	O
Molt	B-cell_line
4	I-cell_line
T	I-cell_line
cells	I-cell_line
or	O
K562	B-cell_line
stem	I-cell_line
cells	I-cell_line
.	O

When	O
ordered	O
according	O
to	O
stage	O
of	O
maturation	O
,	O
the	O
amount	O
of	O
constitutive	O
NF-kappa	B-protein
B	I-protein
was	O
not	O
increased	O
in	O
more	O
mature	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Furthermore	O
,	O
when	O
inducing	O
differentiation	O
in	O
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
cells	I-cell_line
,	O
with	O
vitamin	O
D3	O
,	O
no	O
change	O
in	O
constitutive	O
or	O
inducible	O
NF-kappa	B-protein
B	I-protein
can	O
be	O
detected	O
.	O

Analysis	O
of	O
primary	O
cells	O
revealed	O
substantial	O
constitutive	O
NF-kappa	B-protein
B	I-protein
-binding	O
activity	O
in	O
blood	B-cell_type
monocytes	I-cell_type
,	O
pleural	B-cell_type
macrophages	I-cell_type
and	O
alveolar	B-cell_type
macrophages	I-cell_type
.	O

The	O
constitutive	O
NF-kappa	B-protein
B	I-protein
appears	O
to	O
be	O
functionally	O
active	O
,	O
since	O
a	O
low	O
level	O
of	O
tumour	B-RNA
necrosis	I-RNA
factor	I-RNA
(	I-RNA
TNF	I-RNA
)	I-RNA
transcript	I-RNA
is	O
detectable	O
in	O
monocytes	B-cell_type
,	O
and	O
this	O
level	O
can	O
be	O
increased	O
by	O
blocking	O
transcript	O
degradation	O
using	O
cycloheximide	O
.	O

The	O
level	O
of	O
constitutive	O
NF-kappa	B-protein
B	I-protein
in	O
these	O
cells	O
is	O
variable	O
and	O
is	O
frequently	O
found	O
to	O
be	O
lower	O
in	O
the	O
more	O
mature	B-cell_type
macrophages	I-cell_type
.	O

Constitutive	O
NF-kappa	B-protein
B	I-protein
was	O
not	O
maintained	O
by	O
autocrine	O
action	O
of	O
cytokines	B-protein
TNF	B-protein
,	O
interleukin	B-protein
6	I-protein
,	O
interleukin	B-protein
10	O
,	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
or	O
macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
,	O
since	O
neutralizing	O
antibodies	O
did	O
not	O
reduce	O
constitutive	O
DNA-binding	O
activity	O
.	O

Furthermore	O
,	O
blockade	O
of	O
prostaglandin	O
or	O
leukotriene	O
biosynthesis	O
did	O
not	O
affect	O
constitutive	O
NF-kappa	B-protein
B	I-protein
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
304	NULL
,	NULL
87-94	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
87	NULL
Constitutive	NULL
nuclear	NULL
NF-xB	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
Marion	NULL
FRANKENBERGER	NULL
,	NULL
*	NULL
Almuth	NULL
PFORTE	NULL
,	NULL
{	NULL
Thomas	NULL
STERNSDORF	NULL
,	NULL
*	NULL
Bernward	NULL
PASSLICK	NULL
,	NULL
f	NULL
Patrick	NULL
A.	NULL
BAEUERLE	NULL
,	NULL
§	NULL
and	NULL
H.	NULL
W.	NULL
Loms	NULL
ZIEGLER-HEITBROCK*||	NULL
*Institute	NULL
for	NULL
Immunology	NULL
,	NULL
$	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
{	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
and	NULL
§Gene	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Munich	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
In	NULL
monocytes	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
invoked	NULL
as	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
of	NULL
cell-surface	NULL
receptors	NULL
and	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

In	NULL
such	NULL
cells	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
detected	NULL
without	NULL
intentional	NULL
stimulation	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
cells	NULL
of	NULL
the	NULL
human	NULL
monocytic	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
cultured	NULL
in	NULL
medium	NULL
containing	NULL
fetal-calf	NULL
serum	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
also	NULL
exhibit	NULL
such	NULL
'constitutive	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
mobility-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

This	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
still	NULL
present	NULL
when	NULL
contaminant	NULL
LPS	NULL
was	NULL
removed	NULL
by	NULL
ultrafiltration	NULL
and	NULL
when	NULL
serum	NULL
was	NULL
omitted	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
similar	NULL
in	NULL
mobility	NULL
to	NULL
the	NULL
LPS-induced	NULL
NF-kB	NULL
and	NULL
both	NULL
are	NULL
recognized	NULL
by	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
will	NULL
only	NULL
block	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
the	NULL
constitutive	NULL
binding	NULL
protein	NULL
.	NULL

Using	NULL
LPS-free	NULL
and	NULL
serum-free	NULL
conditions	NULL
,	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
(	NULL
HL60	NULL
,	NULL
U937	NULL
,	NULL
THP	NULL
-1	NULL
,	NULL
Mono	NULL
Mac	NULL
1	NULL
and	NULL
Mono	NULL
Mac	NULL
6	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Molt	NULL
4	NULL
T	NULL
cells	NULL
or	NULL
K562	NULL
stem	NULL
cells	NULL
.	NULL

When	NULL
ordered	NULL
according	NULL
to	NULL
stage	NULL
of	NULL
maturation	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
not	NULL
increased	NULL
in	NULL
more	NULL
mature	NULL
cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
inducing	NULL
differentiation	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
with	NULL
vitamin	NULL
D	NULL
,	NULL
,	NULL
no	NULL
change	NULL
in	NULL
constitutive	NULL
or	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
detected	NULL
.	NULL

Analysis	NULL
of	NULL
primary	NULL
cells	NULL
revealed	NULL
substantial	NULL
constitutive	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
blood	NULL
monocytes	NULL
,	NULL
pleural	NULL
macrophages	NULL
and	NULL
alveolar	NULL
macrophages	NULL
.	NULL

The	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
be	NULL
functionally	NULL
active	NULL
,	NULL
since	NULL
a	NULL
low	NULL
level	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
transcript	NULL
is	NULL
detectable	NULL
in	NULL
monocytes	NULL
,	NULL
and	NULL
this	NULL
level	NULL
can	NULL
be	NULL
increased	NULL
by	NULL
blocking	NULL
transcript	NULL
degradation	NULL
using	NULL
cyclo-heximide	NULL
.	NULL

The	NULL
level	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
variable	NULL
and	NULL
is	NULL
frequently	NULL
found	NULL
to	NULL
be	NULL
lower	NULL
in	NULL
the	NULL
more	NULL
mature	NULL
macrophages	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
not	NULL
maintained	NULL
by	NULL
autocrine	NULL
action	NULL
of	NULL
cytokines	NULL
TNF	NULL
,	NULL
interleukin	NULL
6	NULL
,	NULL
interleukin	NULL
10	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
or	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
since	NULL
neutralizing	NULL
antibodies	NULL
did	NULL
not	NULL
reduce	NULL
constitutive	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
blockade	NULL
of	NULL
prostaglandin	NULL
or	NULL
leukotriene	NULL
biosynthesis	NULL
did	NULL
not	NULL
affect	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
system	NULL
,	NULL
under	NULL
conditions	NULL
that	NULL
exclude	NULL
major	NULL
external	NULL
stimuli	NULL
,	NULL
do	NULL
show	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
nucleus	NULL
without	NULL
an	NULL
apparent	NULL
correlation	NULL
to	NULL
stage	NULL
of	NULL
differentiation	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
DNA-binding	NULL
protein	NULL
interacting	NULL
with	NULL
the	NULL
sequence	NULL
GGGACT-TTCC	NULL
in	NULL
the	NULL
mouse	NULL
Ig	NULL
x	NULL
light-chain	NULL
enhancer	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
and	NULL
thereby	NULL
inducing	NULL
transcription	NULL
of	NULL
the	NULL
x	NULL
light-chain	NULL
gene	NULL
.	NULL

Subsequent	NULL
work	NULL
revealed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
important	NULL
for	NULL
several	NULL
other	NULL
molecules	NULL
expressed	NULL
by	NULL
leucocytes	NULL
,	NULL
including	NULL
cytokines	NULL
like	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
Hoyos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Liebermann	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
heterodimeric	NULL
p50/p65	NULL
protein	NULL
that	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
cells	NULL
in	NULL
a	NULL
complex	NULL
with	NULL
an	NULL
inhibitory	NULL
protein	NULL
(	NULL
IKB	NULL
)	NULL
.	NULL

Only	NULL
after	NULL
cell	NULL
activation	NULL
does	NULL
IxB	NULL
dissociate	NULL
and	NULL
release	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
is	NULL
then	NULL
transported	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Bauerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
system	NULL
(	NULL
myelomonocytic	NULL
stem	NULL
cells	NULL
,	NULL
bone-marrow	NULL
monoblasts	NULL
,	NULL
blood	NULL
monocytes	NULL
,	NULL
tissue	NULL
macro-phages	NULL
)	NULL
form	NULL
a	NULL
central	NULL
element	NULL
in	NULL
immune	NULL
defence	NULL
,	NULL
in	NULL
that	NULL
they	NULL
are	NULL
able	NULL
to	NULL
phagocytose	NULL
foreign	NULL
material	NULL
,	NULL
present	NULL
processed	NULL
antigen	NULL
to	NULL
T	NULL
cells	NULL
and	NULL
orchestrate	NULL
the	NULL
immune	NULL
response	NULL
by	NULL
secretion	NULL
of	NULL
cytokines	NULL
,	NULL
like	NULL
TNF	NULL
,	NULL
IL-1	NULL
and	NULL
IL-6	NULL
.	NULL

Expression	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
system	NULL
can	NULL
be	NULL
strongly	NULL
induced	NULL
by	NULL
the	NULL
bacterial	NULL
product	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
such	NULL
LPS	NULL
stimulation	NULL
also	NULL
results	NULL
in	NULL
mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Shakhov	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Haas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Quite	NULL
in	NULL
contrast	NULL
with	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
similar	NULL
to	NULL
antibody-producing	NULL
B	NULL
cells	NULL
,	NULL
constitutive	NULL
presence	NULL
of	NULL
NF-KB	NULL
in	NULL
nuclei	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
monocytes	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Haas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
one	NULL
study	NULL
it	NULL
was	NULL
claimed	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
will	NULL
increase	NULL
with	NULL
differentiation	NULL
to	NULL
mature	NULL
macrophages	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
sensitivity	NULL
of	NULL
monocytes	NULL
to	NULL
activation	NULL
by	NULL
various	NULL
signals	NULL
and	NULL
,	NULL
most	NULL
noteworthy	NULL
,	NULL
from	NULL
trace	NULL
amounts	NULL
of	NULL
LPS	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Taktak	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
one	NULL
might	NULL
assume	NULL
that	NULL
such	NULL
constitutive	NULL
mobilization	NULL
is	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
induced	NULL
inadvertently	NULL
by	NULL
exogenous	NULL
stimuli	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
a	NULL
set	NULL
of	NULL
human	NULL
cell	NULL
lines	NULL
under	NULL
serum-free	NULL
and	NULL
LPS-free	NULL
conditions	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
such	NULL
exogenous	NULL
stimuli	NULL
,	NULL
cell	NULL
lines	NULL
belonging	NULL
to	NULL
the	NULL
monocyte	NULL
system	NULL
show	NULL
constitutive	NULL
nuclear	NULL
NF-xB	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
we	NULL
found	NULL
,	NULL
however	NULL
,	NULL
no	NULL
apparent	NULL
increase	NULL
during	NULL
differentiation	NULL
.	NULL

MATERIAL	NULL
AND	NULL
METHODS	NULL
Primary	NULL
cells	NULL
Human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
Abbreviations	NULL
used	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
TNF	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor	NULL
;	NULL
IL-2	NULL
,	NULL
-6	NULL
,	NULL
-10	NULL
,	NULL
interleukins	NULL
2	NULL
,	NULL
6	NULL
,	NULL
10	NULL
;	NULL
FCS	NULL
,	NULL
fetal-calf	NULL
serum	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethanesulphony	NULL
!	NULL

fluoride	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
M-CSF	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
MHC	NULL
,	NULL
major	NULL
histocompatability	NULL
complex	NULL
;	NULL
MTT	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethyl-thiazol-2-yl	NULL
2,5-di-phenyltetrazolium-bromide	NULL
)	NULL
;	NULL
NDGA	NULL
,	NULL
nordihydro-	NULL
guaiaretic	NULL
acid	NULL
.	NULL

||	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
,	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Goethestrasse	NULL
31	NULL
,	NULL
8033b	NULL
Munchen	NULL
,	NULL
Germany	NULL
.	NULL

88	NULL
M.	NULL
Frankenberger	NULL
and	NULL
others	NULL
0	NULL
j	NULL
Serum	NULL
,	NULL
LPS	NULL
(	NULL
50	NULL
pg/m	NULL
!	NULL
)	NULL

LPS	NULL
0	NULL
1	NULL
Serum	NULL
,	NULL
no	NULL
LPS	NULL
LPS	NULL
0	NULL
j	NULL
No	NULL
serum	NULL
,	NULL
no	NULL
LPS	NULL
LPS	NULL
Figure	NULL
1	NULL
-	NULL
Constitutive	NULL
NF-xB	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
and	NULL
LPS-free	NULL
and	NULL
serum-free	NULL
conditions	NULL
Mono	NULL
Mac	NULL
6	NULL
ceils	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
with	NULL
medium	NULL
containing	NULL
either	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
small	NULL
amounts	NULL
of	NULL
contaminant	NULL
LPS	NULL
(	NULL
Janes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
or	NULL
10	NULL
%	NULL
FCS	NULL
without	NULL
detectable	NULL
LPS	NULL
(	NULL
fanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
without	NULL
any	NULL
serum	NULL
or	NULL
LPS	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
LPS	NULL
,	NULL
followed	NULL
by	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
gel-shift	NULL
analysis	NULL
.	NULL

NycoPrep	NULL
1.068	NULL
solution	NULL
(	NULL
Nycomed	NULL
Pharma	NULL
AS	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
;	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

223510	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
description	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
10	NULL
vol	NULL
.	NULL

of	NULL
defibrinated	NULL
blood	NULL
from	NULL
healthy	NULL
volunteers	NULL
is	NULL
mixed	NULL
with	NULL
1	NULL
vol	NULL
.	NULL

of	NULL
6	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Dextran	NULL
500	NULL
in	NULL
0.9	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
NaCl	NULL
.	NULL

The	NULL
plasma	NULL
layer	NULL
,	NULL
containing	NULL
the	NULL
leucocytes	NULL
,	NULL
is	NULL
removed	NULL
after	NULL
the	NULL
erythrocytes	NULL
have	NULL
settled	NULL
(	NULL
30-40	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

The	NULL
plasma	NULL
is	NULL
then	NULL
layered	NULL
on	NULL
to	NULL
NycoPrep	NULL
1.068	NULL
and	NULL
centrifuged	NULL
at	NULL
600g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
clear	NULL
plasma	NULL
,	NULL
including	NULL
interface	NULL
and	NULL
NycoPrep	NULL
solution	NULL
,	NULL
is	NULL
collected	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
0.9	NULL
%	NULL
NaCl	NULL
,	NULL
containing	NULL
0.13	NULL
%	NULL
EDTA	NULL
and	NULL
1	NULL
%	NULL
fetal-calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

Separated	NULL
monocytes	NULL
show	NULL
a	NULL
purity	NULL
of	NULL
about	NULL
85-90	NULL
%	NULL
when	NULL
analysed	NULL
for	NULL
CD14	NULL
staining	NULL
in	NULL
flow	NULL
cytometry	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
initial	NULL
sedimentation	NULL
,	NULL
all	NULL
procedures	NULL
were	NULL
performed	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
preparation	NULL
of	NULL
lysates	NULL
directly	NULL
unless	NULL
stimulated	NULL
in	NULL
culture	NULL
medium	NULL
with	NULL
LPS	NULL
at	NULL
1	NULL
ug/ml	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Alveolar	NULL
macrophages	NULL
were	NULL
recovered	NULL
by	NULL
broncho-alveolar	NULL
lavage	NULL
from	NULL
healthy	NULL
volunteers	NULL
after	NULL
informed	NULL
consent	NULL
was	NULL
obtained	NULL
and	NULL
after	NULL
the	NULL
study	NULL
had	NULL
been	NULL
cleared	NULL
by	NULL
the	NULL
Ethics	NULL
Committee	NULL
of	NULL
the	NULL
University	NULL
of	NULL
Munich	NULL
.	NULL

Lavage	NULL
was	NULL
performed	NULL
with	NULL
100	NULL
ml	NULL
of	NULL
prewarmed	NULL
0.9	NULL
%	NULL
NaCl	NULL
and	NULL
the	NULL
fluid	NULL
recovered	NULL
was	NULL
passed	NULL
through	NULL
sterile	NULL
gauze	NULL
and	NULL
admixed	NULL
immediately	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
RPMI	NULL
1640	NULL
culture	NULL
medium	NULL
at	NULL
4°C	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

These	NULL
preparations	NULL
are	NULL
>	NULL
95	NULL
%	NULL
,	NULL
macrophages	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
CD14	NULL
staining	NULL
,	NULL
and	NULL
they	NULL
rarely	NULL
contain	NULL
bronchial	NULL
epithelia	NULL
(	NULL
<	NULL
0.5	NULL
%	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
pleural	NULL
lavage	NULL
preparations	NULL
contain	NULL
only	NULL
a	NULL
few	NULL
mesothelial	NULL
cells	NULL
and	NULL
are	NULL
also	NULL
>	NULL
90	NULL
%	NULL
CDI14-positive	NULL
.	NULL

Cell	NULL
lines	NULL
Cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
1	NULL
and	NULL
Mono	NULL
Mac	NULL
6	NULL
were	NULL
established	NULL
in	NULL
this	NULL
laboratory	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

THP-1	NULL
(	NULL
Tsuchiya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1980	NULL
)	NULL
and	NULL
HL60	NULL
(	NULL
Collins	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
)	NULL
were	NULL
obtained	NULL
courtesy	NULL
of	NULL
R.	NULL
Munker	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
.	NULL

U937	NULL
(	NULL
Sundstrom	NULL
and	NULL
Nilsson	NULL
,	NULL
1976	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
K.	NULL
Nilsson	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
;	NULL
K562	NULL
(	NULL
Lozzio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1976	NULL
)	NULL
and	NULL
Moltd	NULL
(	NULL
Minowada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1972	NULL
)	NULL
from	NULL
L.	NULL
Giirtler	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
newborn-calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Greiner	NULL
,	NULL
Niirtingen	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
and	NULL
L-glutamine	NULL
.	NULL

Mono	NULL
Mac-1	NULL
and	NULL
-6	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
,	NULL
fortified	NULL
as	NULL
described	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

For	NULL
neutralization	NULL
of	NULL
monocyte-derived	NULL
cytokines	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
incubated	NULL
overnight	NULL
with	NULL
antibodies	NULL
raised	NULL
against	NULL
TNF	NULL
(	NULL
rabbit	NULL
antibody	NULL
,	NULL
2	NULL
ug/ml	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
T.	NULL
Subkowski	NULL
,	NULL
BASF-Knoll	NULL
)	NULL
,	NULL
IL-6	NULL
(	NULL
goat	NULL
antibody	NULL
,	NULL
50	NULL
ug/ml	NULL
,	NULL
Janssen	NULL
,	NULL
Hiss	NULL
,	NULL
Freiburg	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
,	NULL
IL-10	NULL
(	NULL
25	NULL
ug/ml	NULL
)	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
M-CSF	NULL
)	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
(	NULL
20	NULL
ug/ml	NULL
)	NULL
(	NULL
all	NULL
goat	NULL
antibodies	NULL
;	NULL
Biermann	NULL
,	NULL
Bad	NULL
Nauheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
culture	NULL
for	NULL
45	NULL
min	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
before	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

For	NULL
induction	NULL
of	NULL
cytokine	NULL
protein	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
4	NULL
h.	NULL
Prostaglandin	NULL
and	NULL
leukotriene	NULL
biosynthesis	NULL
was	NULL
blocked	NULL
by	NULL
overnight	NULL
culture	NULL
with	NULL
1	NULL
x	NULL
10-	NULL
>	NULL
M	NULL
indomethacin	NULL
(	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

I-7378	NULL
,	NULL
Sigma	NULL
)	NULL
or	NULL
with	NULL
5	NULL
x	NULL
10~°	NULL
M	NULL
nordihydroguaiaretic	NULL
acid	NULL
(	NULL
NDGA	NULL
)	NULL
(	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

N-1144	NULL
,	NULL
Sigma	NULL
)	NULL
respectively	NULL
.	NULL

Bioassays	NULL
for	NULL
TNF	NULL
and	NULL
IL-6	NULL
TNF	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
Wehil648/actinomycin	NULL
D	NULL
cytotoxicity	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
100	NULL
41	NULL
of	NULL
Wehil648	NULL
cells	NULL
were	NULL
incubated	NULL
overnight	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
and	NULL
were	NULL
seeded	NULL
at	NULL
1	NULL
x	NULL
10°	NULL
cells/well	NULL
into	NULL
96-well	NULL
flat-bottomed	NULL
microtitre	NULL
plates	NULL
.	NULL

To	NULL
this	NULL
,	NULL
was	NULL
added	NULL
in	NULL
duplicate	NULL
threefold	NULL
serial	NULL
dilutions	NULL
of	NULL
cytokine-containing	NULL
supernatants	NULL
.	NULL

After	NULL
overnight	NULL
culture	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
tetrazolium	NULL
salt	NULL
(	NULL
MTT	NULL
,	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

M-2128	NULL
,	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
for	NULL
4h	NULL
and	NULL
any	NULL
crystals	NULL
formed	NULL
were	NULL
dissolved	NULL
in	NULL
SDS/HCI	NULL
.	NULL

Absorbance	NULL
was	NULL
determined	NULL
in	NULL
an	NULL
e.1.i.s.a	NULL
.	NULL

reader	NULL
and	NULL
units	NULL
of	NULL
TNF	NULL
were	NULL
calculated	NULL
with	NULL
reference	NULL
to	NULL
a	NULL
recombinant	NULL
TNF	NULL
standard	NULL
.	NULL

IL-6	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
7TD1	NULL
proliferation	NULL
assay	NULL
(	NULL
van	NULL
Snick	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
100	NULL
gl	NULL
of	NULL
7TD1	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
5000	NULL
cells	NULL
per	NULL
well	NULL
in	NULL
flat-bottomed	NULL
microtitre	NULL
plates	NULL
together	NULL
with	NULL
duplicate	NULL
twofold	NULL
serial	NULL
dilutions	NULL
of	NULL
20	NULL
ul	NULL
culture	NULL
supernatants	NULL
.	NULL

After	NULL
culture	NULL
for	NULL
3	NULL
days	NULL
,	NULL
viable	NULL
cells	NULL
were	NULL
determined	NULL
with	NULL
MTT	NULL
as	NULL
given	NULL
above	NULL
for	NULL
the	NULL
TNF	NULL
assay	NULL
.	NULL

Units	NULL
of	NULL
IL-6	NULL
were	NULL
calculated	NULL
with	NULL
reference	NULL
to	NULL
a	NULL
recombinant	NULL
IL-6	NULL
standard	NULL
.	NULL

Detection	NULL
and	NULL
removal	NULL
of	NULL
LPS	NULL
LPS	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
Pyrogent	NULL
limulus	NULL
amoebocyte	NULL
lysate	NULL
(	NULL
LAL	NULL
)	NULL
assay	NULL
(	NULL
Byk-Santec	NULL
,	NULL
Dietzenbach	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
which	NULL
had	NULL
a	NULL
Constitutive	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
89	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
a	NULL
)	NULL
Mono	NULL
Mac	NULL
6	NULL
+LPS	NULL
Competitor	NULL
...	NULL
-	NULL
0	NULL
0.25	NULL
25	NULL
25	NULL
0	NULL
0.2525	NULL
25	NULL
Serum	NULL
:	NULL
Ww	NULL
_	NULL
tug	NULL
vs	NULL
wiiile	NULL
oi	NULL
)	NULL
Figure	NULL
2	NULL
-	NULL
Characterization	NULL
of	NULL
constitutive	NULL
NF-B	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
b	NULL
)	NULL
Mono	NULL
Mac	NULL
6	NULL
_7+7LPS	NULL
LPS	NULL
-	NULL
+	NULL
-	NULL
+	NULL
(	NULL
c	NULL
)	NULL
PDTC	NULL
+0	NULL
+	NULL
Anit-p50	NULL
Preimmune	NULL
Anit-p50	NULL
Preimmune	NULL
+	NULL
+	NULL
=	NULL
f\	NULL
%	NULL
bg	NULL
i	NULL
€	NULL
1	NULL
(	NULL
a	NULL
)	NULL
Competition	NULL
by	NULL
a	NULL
KB	NULL
oligonucleotide	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
or	NULL
LPS-stimulated	NULL
cells	NULL
were	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
competitor	NULL
derived	NULL
from	NULL
the	NULL
HLA-A	NULL
,	NULL
enhancer	NULL
added	NULL
as	NULL
0.25	NULL
,	NULL
2.5	NULL
or	NULL
25	NULL
ng	NULL
per	NULL
lane	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Supershift	NULL
by	NULL
anti-p50	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
or	NULL
from	NULL
LPS-treated	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
incubated	NULL
without	NULL
serum	NULL
,	NULL
with	NULL
anti-p50	NULL
antibody	NULL
or	NULL
with	NULL
preimmune	NULL
serum	NULL
.	NULL

(	NULL
€	NULL
)	NULL
Effect	NULL
of	NULL
PDTC	NULL
.	NULL

Mone	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
1	NULL
h	NULL
with	NULL
or	NULL
without	NULL
PDTC	NULL
at	NULL
300	NULL
M	NULL
followed	NULL
by	NULL
30	NULL
min	NULL
culture	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
.	NULL

4	NULL
0	NULL
o.	NULL
o	NULL
.	NULL

S	NULL
-d	NULL
+	NULL
+	NULL
u	NULL
-	NULL
~	NULL
©	NULL
©	NULL
9	NULL
9	NULL
o	NULL
o	NULL
Os	NULL
w	NULL
w	NULL
w	NULL
Y	NULL
4	NULL
4	NULL
i	NULL
<	NULL
%	NULL
&	NULL
;	NULL
&	NULL
&	NULL
,	NULL
q	NULL
s	NULL
B	NULL
s	NULL
&	NULL
F	NULL
&	NULL
+	NULL
+	NULL
t	NULL
_	NULL
_-	NULL
09	NULL
0	NULL
o	NULL
o	NULL
JJNNOONNQLDL	NULL
‘	NULL
ZZZZ	NULL
o	NULL
0	NULL
&	NULL
&	NULL
§	NULL
9	NULL
&	NULL
&	NULL
&	NULL
§	NULL
}	NULL
o	NULL
o	NULL
6	NULL
o	NULL
=	NULL
E	NULL
xox	NULL
I	NULL
I	NULL
5	NULL
5	NULL
F	NULL
-	NULL
E	NULL
E	NULL
E	NULL
&	NULL
but	NULL
tib	NULL
tus	NULL
but	NULL
+	NULL
»	NULL
(	NULL
B	NULL
)	NULL
s	NULL
»	NULL
fil	NULL
)	NULL
un	NULL
GD	NULL
is	NULL
tno	NULL
bs	NULL
Figure	NULL
3	NULL
-	NULL
Constitutive	NULL
NF-xB	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
cultured	NULL
under	NULL
LPS-free	NULL
conditions	NULL
Cell	NULL
lines	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
medium	NULL
depleted	NULL
of	NULL
LPS	NULL
by	NULL
ultrafiltration	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Before	NULL
preparation	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
one	NULL
sample	NULL
of	NULL
each	NULL
was	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
1	NULL
h.	NULL
sensitivity	NULL
of	NULL
10-25	NULL
pg/ml	NULL
when	NULL
using	NULL
Salmonella	NULL
minnesota	NULL
LPS	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

For	NULL
removal	NULL
of	NULL
LPS	NULL
,	NULL
culture	NULL
medium	NULL
(	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
FCS	NULL
)	NULL
was	NULL
passed	NULL
through	NULL
a	NULL
Gambro	NULL
2000	NULL
ultrafiltration	NULL
column	NULL
(	NULL
Gambro	NULL
,	NULL
Hechingen	NULL
,	NULL
Germany	NULL
)	NULL
(	NULL
Blumenstein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Cycloheximide	NULL
(	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

C-6255	NULL
,	NULL
Sigma	NULL
)	NULL
was	NULL
found	NULL
to	NULL
be	NULL
LAL-negative	NULL
(	NULL
<	NULL
10	NULL
pg/ml	NULL
)	NULL
Treatment	NULL
with	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
and	NULL
without	NULL
PDTC	NULL
at	NULL
300	NULL
4M	NULL
for	NULL
1	NULL
h	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
30	NULL
min	NULL
culture	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
at	NULL
30	NULL
ng/ml	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
Cells	NULL
with	NULL
or	NULL
without	NULL
1	NULL
h	NULL
stimulation	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
1	NULL
ug/ml	NULL
LPS	NULL
were	NULL
extracted	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Haas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
after	NULL
incubation	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
hypotonic	NULL
buffer	NULL
,	NULL
they	NULL
were	NULL
subjected	NULL
to	NULL
cycles	NULL
of	NULL
ultrasound	NULL
(	NULL
5	NULL
s	NULL
each	NULL
)	NULL
,	NULL
such	NULL
that	NULL
over	NULL
70	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
free	NULL
nuclei	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
high-salt	NULL
buffer	NULL
.	NULL

After	NULL
40	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
buffer	NULL
D.	NULL
Care	NULL
was	NULL
taken	NULL
to	NULL
add	NULL
1	NULL
41	NULL
of	NULL
phenyImethanesulphonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
to	NULL
the	NULL
preparation	NULL
at	NULL
every	NULL
step	NULL
of	NULL
the	NULL
procedure	NULL
.	NULL

Protein	NULL
content	NULL
of	NULL
the	NULL
preparation	NULL
was	NULL
determined	NULL
by	NULL
Coomassie	NULL
Blue	NULL
reaction	NULL
,	NULL
using	NULL
the	NULL
Bio-Rad	NULL
kit	NULL
(	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

500-0006	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

If	NULL
required	NULL
,	NULL
aliquotted	NULL
extracts	NULL
were	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Contamination	NULL
of	NULL
nuclear	NULL
extracts	NULL
by	NULL
cytosolic	NULL
proteins	NULL
can	NULL
not	NULL
be	NULL
completely	NULL
excluded	NULL
with	NULL
the	NULL
preparation	NULL
method	NULL
used	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
,	NULL
however	NULL
,	NULL
also	NULL
obtained	NULL
with	NULL
extracts	NULL
prepared	NULL
using	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

Furthermore	NULL
,	NULL
cytosolic	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
bound	NULL
to	NULL
inhibitory	NULL
proteins	NULL
(	NULL
IxB	NULL
,	NULL
C-terminal	NULL
part	NULL
of	NULL
p105	NULL
)	NULL
,	NULL
which	NULL
have	NULL
to	NULL
be	NULL
removed	NULL
by	NULL
deoxycholate	NULL
treatment	NULL
in	NULL
order	NULL
to	NULL
give	NULL
binding	NULL
to	NULL
their	NULL
cognate	NULL
DNA	NULL
.	NULL

Gel-shift	NULL
analysis	NULL
Gel	NULL
shift	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
using	NULL
a	NULL
**P	NULL
labelled	NULL
«	NULL
B	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
«	NULL
B	NULL
light-chain	NULL
enhancer	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

For	NULL
inhibition	NULL
studies	NULL
,	NULL
labelled	NULL
oligonucleotide	NULL
was	NULL
mixed	NULL
with	NULL
0.25	NULL
ng	NULL
,	NULL
2.5	NULL
ng	NULL
and	NULL
25	NULL
ng	NULL
excess	NULL
of	NULL
unlabelled	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
HLA-A	NULL
,	NULL
enhancer	NULL
.	NULL

The	NULL
anti-p50	NULL
antibody	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Israel	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
,	NULL
was	NULL
added	NULL
as	NULL
1	NULL
wl	NULL
of	NULL
undiluted	NULL
serum	NULL
to	NULL
the	NULL
nuclear	NULL
extract	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
**P	NULL
90	NULL
M.	NULL
Frankenberger	NULL
and	NULL
others	NULL
My4	NULL
(	NULL
a	NULL
)	NULL
0	NULL
+VD3	NULL
(	NULL
b	NULL
)	NULL
10	NULL
-	NULL
200	NULL
-	NULL
400	NULL
600	NULL
_	NULL
800	NULL
1000	NULL
10	NULL
_	NULL
200	NULL
400	NULL
600	NULL
_	NULL
800	NULL
1000	NULL
0	NULL
+LPS	NULL
``	NULL
0	NULL
J	NULL
i	NULL
caa	NULL
uaa	NULL
l	NULL
uu	NULL
Logo	NULL
gor	NULL
Paga	NULL
sf	NULL
T	NULL
‘	NULL
AAA	NULL
,	NULL
J_L_J_A_I_A_LL_A_A_1__LLJ.J	NULL
,	NULL
LLiJL11	NULL
4	NULL
|	NULL
]	NULL
4	NULL
|	NULL
|	NULL
|	NULL
i	NULL
poA	NULL
#	NULL
|	NULL
|	NULL
q	NULL
I	NULL
]	NULL
it	NULL
7	NULL
-	NULL
[	NULL
PJ	NULL
E	NULL
j	NULL
]	NULL
is	NULL
”	NULL
;	NULL
4	NULL
¢	NULL
ll	NULL
PAs	NULL
j	NULL
j	NULL
\	NULL
|	NULL
*-y	NULL
l	NULL
]	NULL
¥	NULL
1	NULL
|	NULL
f	NULL
'	NULL
}	NULL
fo	NULL
}	NULL
|	NULL
Eo	NULL
y	NULL
[	NULL
oo	NULL
G	NULL
~	NULL
¥	NULL
o	NULL
|	NULL
|	NULL
b	NULL
4	NULL
U	NULL
“	NULL
|	NULL
-	NULL
i	NULL
s	NULL
A	NULL
|	NULL
|	NULL
Paky	NULL
.	NULL

,	NULL
-	NULL
f	NULL
x	NULL
``	NULL
\	NULL
|	NULL
7	NULL
``	NULL
gram—Ti	NULL
?	NULL

“	NULL
”	NULL
Hui	NULL
i	NULL
MfY	NULL
i	NULL
10°	NULL
10	NULL
}	NULL
10+	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
10°	NULL
10°	NULL
10+	NULL
i	NULL
F	NULL
Fluorescence	NULL
intensity	NULL
fee	NULL
's	NULL
0	NULL
+VD3	NULL
Mo2	NULL
10	NULL
200	NULL
400	NULL
600	NULL
800	NULL
1000	NULL
10	NULL
200	NULL
400	NULL
600	NULL
800	NULL
1000	NULL
cca	NULL
d	NULL
g	NULL
uaa	NULL
f	NULL
g	NULL
gala	NULL
f	NULL
agua	NULL
F	NULL
L	NULL
rien	NULL
6	NULL
Lup	NULL
por	NULL
1334	NULL
1T	NULL
tp	NULL
gga	NULL
y	NULL
.	NULL

1.4.41	NULL
|	NULL
|	NULL
|	NULL
]	NULL
|	NULL
|	NULL
1	NULL
|	NULL
{	NULL
|	NULL
]	NULL
‘	NULL
f.	NULL
|	NULL
{	NULL
‘	NULL
E4	NULL
.	NULL
]	NULL

|	NULL
|	NULL
|	NULL
]	NULL
[	NULL
8	NULL
|	NULL
60	NULL
}	NULL
4	NULL
||V|~1	NULL
R	NULL
1	NULL
(	NULL
]	NULL
JF	NULL
4	NULL
<	NULL
£0	NULL
]	NULL
fo	NULL
%	NULL
yaad	NULL
k	NULL
¢	NULL
s	NULL
]	NULL
x	NULL
int	NULL
bw	NULL
%	NULL
,	NULL
i	NULL
‘	NULL
fvvw	NULL
‘	NULL
ﬂ	NULL
‘	NULL
u	NULL
t-t	NULL
VF'QVW	NULL
<	NULL
‘	NULL
A'rgva	NULL
‘	NULL
V—rﬁrH—w—r—T-WTTTT—ﬁ—hv	NULL
‘	NULL
rr	NULL
‘	NULL
10°	NULL
10	NULL
'	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
'	NULL
k	NULL
10°	NULL
104	NULL
Fluorescence	NULL
intensity	NULL
0	NULL
+VD3	NULL
Figure	NULL
4	NULL
-	NULL
Effect	NULL
of	NULL
differentiation	NULL
induction	NULL
by	NULL
vitamin	NULL
D	NULL
,	NULL
(	NULL
a	NULL
)	NULL
Effect	NULL
on	NULL
CD14	NULL
expression	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
with	NULL
or	NULL
without	NULL
vitamin	NULL
D	NULL
;	NULL
(	NULL
160	NULL
nM	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
anti-CD14	NULL
antibodies	NULL
My4	NULL
or	NULL
Mo	NULL
,	NULL
or	NULL
the	NULL
respective	NULL
isotype	NULL
controls	NULL
(	NULL
dotted	NULL
lines	NULL
)	NULL
.	NULL

Fluorescence	NULL
intensity	NULL
for	NULL
My4	NULL
increased	NULL
from	NULL
557	NULL
to	NULL
716	NULL
channels	NULL
,	NULL
and	NULL
percentage	NULL
of	NULL
Mo2	NULL
positives	NULL
from	NULL
5	NULL
to	NULL
87.1	NULL
%	NULL
in	NULL
this	NULL
example	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
cells	NULL
and	NULL
assayed	NULL
in	NULL
gel-shift	NULL
analysis	NULL
labelled	NULL
oligonucleotide	NULL
.	NULL

Samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
4	NULL
%	NULL
poly-acrylamide	NULL
gel	NULL
and	NULL
the	NULL
dried	NULL
gel	NULL
was	NULL
applied	NULL
to	NULL
an	NULL
X-ray	NULL
film	NULL
at	NULL
-80	NULL
°C	NULL
overnight	NULL
.	NULL

Northern-blot	NULL
analysis	NULL
For	NULL
Northern-blot	NULL
analysis	NULL
,	NULL
mRNA	NULL
was	NULL
isolated	NULL
using	NULL
RNAzol	NULL
B	NULL
(	NULL
WAK	NULL
,	NULL
Bad	NULL
Homburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Samples	NULL
(	NULL
10	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
and	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
labelled	NULL
with	NULL
**P	NULL
by	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tailing	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
TNF	NULL
(	NULL
Nedwin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
(	NULL
residues	NULL
89-70	NULL
)	NULL
5-GGTCTGGTAGGAGACGGCGATGC-GGCTGATGGTGTGGGTGAGGAGCACATGGGTGGA-	NULL
and	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
(	NULL
Dugaiczyk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
(	NULL
residues	NULL
17-2	NULL
)	NULL
5-CCC-TGGTGACCAGGCGGCCAATACGGCCAAATCCGTTG-	NULL
RESULTS	NULL
Constitutive	NULL
NF-xB	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
cultured	NULL
in	NULL
standard	NULL
culture	NULL
medium	NULL
with	NULL
FCS	NULL
demonstrate	NULL
'constitutive	NULL
'	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
stimulation	NULL
with	NULL
LPS	NULL
for	NULL
1	NULL
h	NULL
can	NULL
strongly	NULL
increase	NULL
this	NULL
activity	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Culture	NULL
medium	NULL
may	NULL
contain	NULL
substantial	NULL
amounts	NULL
of	NULL
LPS	NULL
,	NULL
introduced	NULL
by	NULL
inadvertent	NULL
contamination	NULL
,	NULL
and	NULL
such	NULL
contaminating	NULL
LPS	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
'constitutive	NULL
'	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
seen	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
employed	NULL
in	NULL
these	NULL
initial	NULL
experiments	NULL
,	NULL
when	NULL
tested	NULL
by	NULL
the	NULL
Limulus	NULL
assay	NULL
,	NULL
in	NULL
fact	NULL
contained	NULL
about	NULL
50	NULL
pg	NULL
of	NULL
LPS/ml	NULL
.	NULL

Culture	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
in	NULL
medium	NULL
rendered	NULL
free	NULL
of	NULL
LPS	NULL
by	NULL
ultrafiltration	NULL
did	NULL
,	NULL
however	NULL
,	NULL
not	NULL
remove	NULL
the	NULL
'constitutive	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
by	NULL
LPS	NULL
was	NULL
still	NULL
apparent	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
used	NULL
contained	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
this	NULL
may	NULL
have	NULL
contained	NULL
additional	NULL
factors	NULL
involved	NULL
in	NULL
activation	NULL
of	NULL
monocytes	NULL
.	NULL

Even	NULL
with	NULL
omission	NULL
of	NULL
FCS	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
was	NULL
still	NULL
clearly	NULL
evident	NULL
(	NULL
Figure	NULL
1	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
monocytes	NULL
may	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
be	NULL
capable	NULL
of	NULL
mobilizing	NULL
NF-	NULL
«	NULL
B	NULL
independent	NULL
of	NULL
external	NULL
signals	NULL
.	NULL

Next	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
detected	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
under	NULL
these	NULL
conditions	NULL
does	NULL
have	NULL
properties	NULL
similar	NULL
to	NULL
the	NULL
LPS-induced	NULL
nuclear	NULL
factor	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
constitutive	NULL
binding	NULL
activity	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
a	NULL
prototypic	NULL
DNA	NULL
sequence	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
enhancer	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

Non-radioactive	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
added	NULL
in	NULL
increasing	NULL
amounts	NULL
(	NULL
lanes	NULL
2-4	NULL
,	NULL
lanes	NULL
6-8	NULL
)	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
(	NULL
a	NULL
)	NULL
,	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
LPS-induced	NULL
NF-KB	NULL
,	NULL
is	NULL
competed	NULL
for	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
signals	NULL
have	NULL
similar	NULL
specificities	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
antiserum	NULL
against	NULL
p50	NULL
equally	NULL
recognized	NULL
the	NULL
constitutive	NULL
and	NULL
the	NULL
LPS	NULL
Constitutive	NULL
nuclear	NULL
NF-B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
91	NULL
induced	NULL
band	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
further	NULL
shift	NULL
to	NULL
higher	NULL
molecular	NULL
mass	NULL
,	NULL
due	NULL
to	NULL
complexing	NULL
with	NULL
the	NULL
antibody	NULL
(	NULL
Figure	NULL
2b	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
with	NULL
PDTC	NULL
did	NULL
not	NULL
,	NULL
however	NULL
,	NULL
reduce	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
while	NULL
the	NULL
LPS-induced	NULL
binding	NULL
protein	NULL
was	NULL
strongly	NULL
reduced	NULL
(	NULL
Figure	NULL
2¢	NULL
)	NULL
.	NULL

In	NULL
an	NULL
average	NULL
of	NULL
six	NULL
experiments	NULL
,	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
reduced	NULL
by	NULL
66.3	NULL
+	NULL
29.8	NULL
%	NULL
,	NULL
while	NULL
the	NULL
level	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
PDTC-treated	NULL
cells	NULL
was	NULL
reduced	NULL
by	NULL
9.6+	NULL
12.6	NULL
%	NULL
,	NULL
of	NULL
the	NULL
untreated	NULL
control	NULL
.	NULL

Constitutive	NULL
NF-xB	NULL
in	NULL
cell	NULL
lines	NULL
of	NULL
different	NULL
degrees	NULL
of	NULL
maturation	NULL
When	NULL
testing	NULL
a	NULL
panel	NULL
of	NULL
cell	NULL
lines	NULL
cultured	NULL
in	NULL
FCS-containing	NULL
LPS-free	NULL
culture	NULL
medium	NULL
,	NULL
we	NULL
detected	NULL
no	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Molt4	NULL
T	NULL
cells	NULL
in	NULL
K562	NULL
haematopoetic	NULL
stem	NULL
cells	NULL
A	NULL
higher-mobility	NULL
band	NULL
seen	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
also	NULL
in	NULL
THP-1	NULL
cells	NULL
is	NULL
variable	NULL
,	NULL
and	NULL
in	NULL
competition	NULL
analysis	NULL
turns	NULL
out	NULL
to	NULL
be	NULL
non-specific	NULL
{	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
myelomonocytic	NULL
stem-cell	NULL
line	NULL
HL60	NULL
does	NULL
,	NULL
however	NULL
,	NULL
express	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
the	NULL
committed	NULL
U937	NULL
line	NULL
,	NULL
representing	NULL
the	NULL
stage	NULL
of	NULL
monoblasts	NULL
,	NULL
showed	NULL
detectable	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
in	NULL
untreated	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
more	NULL
mature	NULL
promonocytic	NULL
lines	NULL
THP-1	NULL
and	NULL
Mono	NULL
Mac	NULL
1	NULL
were	NULL
positive	NULL
,	NULL
as	NULL
was	NULL
the	NULL
most	NULL
mature	NULL
monocytic	NULL
Mono	NULL
Mac	NULL
6	NULL
line	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
earlier	NULL
suggestion	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
increase	NULL
with	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
we	NULL
do	NULL
not	NULL
see	NULL
an	NULL
obvious	NULL
increase	NULL
from	NULL
myelomonocytic	NULL
stem	NULL
cells	NULL
towards	NULL
monocytic	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
,	NULL
however	NULL
,	NULL
a	NULL
trend	NULL
towards	NULL
higher	NULL
LPS-inducible	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
with	NULL
increasing	NULL
maturation	NULL
in	NULL
that	NULL
the	NULL
three	NULL
promonocytic	NULL
and	NULL
monocytic	NULL
lines	NULL
exhibited	NULL
high	NULL
binding	NULL
compared	NULL
with	NULL
the	NULL
stem-cell	NULL
line	NULL
and	NULL
the	NULL
immature	NULL
monoblastic	NULL
line	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
was	NULL
observed	NULL
when	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
FCS-free	NULL
medium	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
still	NULL
present	NULL
and	NULL
there	NULL
was	NULL
again	NULL
no	NULL
increase	NULL
with	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Next	NULL
we	NULL
asked	NULL
whether	NULL
differentiation	NULL
induction	NULL
of	NULL
the	NULL
Mono	NULL
Mac	NULL
6	NULL
cell	NULL
line	NULL
will	NULL
upregulate	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
cells	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
vitamin	NULL
D	NULL
,	NULL
do	NULL
show	NULL
enhanced	NULL
phagocytosis	NULL
(	NULL
16.6	NULL
in	NULL
controls	NULL
,	NULL
39.3	NULL
+	NULL
31.8	NULL
in	NULL
vitamin	NULL
D	NULL
,	NULL
-treated	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
they	NULL
showed	NULL
a	NULL
further	NULL
upregulation	NULL
of	NULL
the	NULL
CD14	NULL
molecule	NULL
.	NULL

The	NULL
staining	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
-treated	NULL
cells	NULL
with	NULL
the	NULL
antibody	NULL
My4	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
from	NULL
557	NULL
to	NULL
716	NULL
in	NULL
the	NULL
example	NULL
in	NULL
Figure	NULL
4	NULL
(	NULL
a	NULL
)	NULL
,	NULL
and	NULL
the	NULL
antibody	NULL
Mo2	NULL
stained	NULL
less	NULL
than	NULL
5	NULL
%	NULL
in	NULL
untreated	NULL
and	NULL
87.1	NULL
%	NULL
in	NULL
the	NULL
vitamin	NULL
D	NULL
,	NULL
-treated	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
vitamin	NULL
D	NULL
,	NULL
can	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
induce	NULL
maturation	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
was	NULL
,	NULL
however	NULL
,	NULL
not	NULL
affected	NULL
by	NULL
such	NULL
treatment	NULL
(	NULL
Figure	NULL
4b	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Primary	NULL
cells	NULL
As	NULL
one	NULL
source	NULL
of	NULL
tissue	NULL
macrophages	NULL
,	NULL
we	NULL
used	NULL
cells	NULL
obtained	NULL
by	NULL
pleural	NULL
lavage	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
such	NULL
pleural	NULL
macrophages	NULL
was	NULL
found	NULL
to	NULL
be	NULL
lower	NULL
(	NULL
Figure	NULL
Sa	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
similar	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
to	NULL
the	NULL
level	NULL
found	NULL
in	NULL
the	NULL
blood	NULL
monocytes	NULL
from	NULL
an	NULL
unrelated	NULL
control	NULL
donor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Next	NULL
we	NULL
tested	NULL
pairs	NULL
of	NULL
primary	NULL
monocytes	NULL
and	NULL
tissue	NULL
macrophages	NULL
,	NULL
obtained	NULL
from	NULL
the	NULL
same	NULL
donor	NULL
.	NULL

In	NULL
the	NULL
example	NULL
in	NULL
Figure	NULL
5b	NULL
,	NULL
paired	NULL
blood	NULL
monocytes	NULL
and	NULL
alveolar	NULL
macrophages	NULL
were	NULL
isolated	NULL
from	NULL
two	NULL
apparently	NULL
healthy	NULL
volun-teers	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
clearly	NULL
lower	NULL
in	NULL
the	NULL
alveolar	NULL
macrophages	NULL
in	NULL
both	NULL
cases	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
among	NULL
primary	NULL
cells	NULL
,	NULL
the	NULL
tissue	NULL
macrophages	NULL
,	NULL
compared	NULL
with	NULL
blood	NULL
monocytes	NULL
,	NULL
do	NULL
not	NULL
show	NULL
higher	NULL
levels	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
most	NULL
cases	NULL
.	NULL

Thus	NULL
in	NULL
the	NULL
monocyte	NULL
lineage	NULL
,	NULL
an	NULL
increase	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
maturation	NULL
is	NULL
not	NULL
apparent	NULL
from	NULL
these	NULL
results	NULL
.	NULL

(	NULL
a	NULL
)	NULL
4	NULL
a.	NULL
o	NULL
ad	NULL
o	NULL
o	NULL
+	NULL
o	NULL
5	NULL
3	NULL
3	NULL
2	NULL
ad	NULL
al	NULL
zal	NULL
a	NULL
a.	NULL
a.	NULL
a	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Mono	NULL
0	NULL
AM	NULL
0	NULL
Mono	NULL
0	NULL
AM	NULL
0	NULL
Figure	NULL
5	NULL
-	NULL
Comparison	NULL
of	NULL
NF-xB	NULL
binding	NULL
activity	NULL
in	NULL
blood	NULL
monocytes	NULL
and	NULL
tissue	NULL
macrophages	NULL
(	NULL
a	NULL
)	NULL
Constitutive	NULL
NF-xB	NULL
in	NULL
blood	NULL
monacytes	NULL
and	NULL
pleural	NULL
macrophages	NULL
.	NULL

Monecytes	NULL
were	NULL
isolated	NULL
to	NULL
<	NULL
88	NULL
%	NULL
purity	NULL
by	NULL
NycoPrep	NULL
separation	NULL
from	NULL
a	NULL
control	NULL
donor	NULL
,	NULL
pleural	NULL
macrophages	NULL
were	NULL
recovered	NULL
from	NULL
patients	NULL
with	NULL
bronchial	NULL
carcinoma	NULL
before	NULL
lobe	NULL
resection	NULL
.	NULL

(	NULL
)	NULL
Constitutive	NULL
NF-xB	NULL
in	NULL
monocytes	NULL
and	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Monocytes	NULL
were	NULL
isolated	NULL
to	NULL
<	NULL
88	NULL
%	NULL
purity	NULL
from	NULL
blood	NULL
;	NULL
alveolar	NULL
macrophages	NULL
from	NULL
the	NULL
same	NULL
healthy	NULL
volunteers	NULL
were	NULL
recovered	NULL
by	NULL
bronchoalveolar	NULL
lavage	NULL
.	NULL

Constitutive	NULL
TNF	NULL
gene	NULL
expression	NULL
Finally	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
constitutive	NULL
NF-KB	NULL
detectable	NULL
in	NULL
nuclei	NULL
of	NULL
monocytes	NULL
might	NULL
be	NULL
of	NULL
functional	NULL
importance	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
studied	NULL
mRNA	NULL
levels	NULL
of	NULL
TNF	NULL
,	NULL
a	NULL
gene	NULL
which	NULL
is	NULL
transcriptionally	NULL
controlled	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Figure	NULL
6	NULL
(	NULL
a	NULL
)	NULL
shows	NULL
that	NULL
Molt4	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
no	NULL
constitutive	NULL
NF-KB	NULL
,	NULL
also	NULL
show	NULL
92	NULL
M.	NULL
Frankenberger	NULL
and	NULL
others	NULL
Molt4	NULL
HL60	NULL
U937	NULL
THP1	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
a	NULL
)	NULL
LPS	NULL
-	NULL
-	NULL
-o	NULL
$	NULL
o	NULL
os	NULL
owo	NULL
o	NULL
ge	NULL
0	NULL
se	NULL
po	NULL
owe	NULL
&	NULL
CHX	NULL
-	NULL
+	NULL
TNF	NULL
X	NULL
o	NULL
(	NULL
b	NULL
)	NULL
5	NULL
&	NULL
0	NULL
+0	NULL
+	NULL
wag	NULL
Figure	NULL
6	NULL
-	NULL
Constitutive	NULL
TNF	NULL
mRNA	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
(	NULL
a	NULL
)	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
unstimulated	NULL
and	NULL
LPS-stimulated	NULL
cells	NULL
and	NULL
10	NULL
g	NULL
per	NULL
lane	NULL
was	NULL
separated	NULL
by	NULL
agarose	NULL
gels	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
hybridized	NULL
with	NULL
a	NULL
TNF	NULL
probe	NULL
and	NULL
a	NULL
GAPDH	NULL
probe	NULL
.	NULL

For	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
g/m	NULL
}	NULL
CHX	NULL
for	NULL
2	NULL
h.	NULL
Higher-molecular-mass	NULL
transcripts	NULL
were	NULL
seen	NULL
in	NULL
Mone	NULL
Mac	NULL
6	NULL
cells	NULL
for	NULL
both	NULL
TNF	NULL
and	NULL
GAPDH	NULL
.	NULL

The	NULL
biological	NULL
significance	NULL
of	NULL
these	NULL
additional	NULL
RNAs	NULL
is	NULL
unknown	NULL
.	NULL

(	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
90	NULL
min	NULL
with	NULL
CHX	NULL
at	NULL
10	NULL
g/ml	NULL
or	NULL
,	NULL
for	NULL
comparison	NULL
,	NULL
with	NULL
LPS	NULL
.	NULL

no	NULL
evidence	NULL
of	NULL
constitutive	NULL
TNF	NULL
transcripts	NULL
.	NULL

HL60	NULL
myelomonocytic	NULL
stem	NULL
cells	NULL
and	NULL
THP-1	NULL
monoblastic	NULL
cells	NULL
,	NULL
both	NULL
of	NULL
which	NULL
express	NULL
constitutive	NULL
NF-KB	NULL
,	NULL
also	NULL
exhibit	NULL
constitutive	NULL
TNF	NULL
transcripts	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
monocytic	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
also	NULL
clearly	NULL
show	NULL
constitutive	NULL
TNF	NULL
mRNA	NULL
.	NULL

Only	NULL
in	NULL
the	NULL
monoblastic	NULL
U937	NULL
cell	NULL
line	NULL
,	NULL
was	NULL
no	NULL
TNF	NULL
mRNA	NULL
detectable	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
LPS	NULL
stimulation	NULL
substantially	NULL
increased	NULL
TNF	NULL
mRNA	NULL
prevalence	NULL
.	NULL

Since	NULL
cytokine	NULL
transcripts	NULL
are	NULL
subject	NULL
to	NULL
rapid	NULL
degradation	NULL
by	NULL
protein-synthesis-dependent	NULL
mechanisms	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
constitutive	NULL
levels	NULL
of	NULL
mRNA	NULL
might	NULL
be	NULL
enhanced	NULL
by	NULL
blockade	NULL
of	NULL
degradation	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
treated	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
with	NULL
cycloheximide	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
90-120	NULL
min	NULL
.	NULL

Such	NULL
treatment	NULL
did	NULL
not	NULL
affect	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
Figure	NULL
6b	NULL
)	NULL
,	NULL
but	NULL
TNF	NULL
mRNA	NULL
was	NULL
enhanced	NULL
2.5-fold	NULL
(	NULL
Figure	NULL
6b	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
drive	NULL
transcription	NULL
,	NULL
an	NULL
effect	NULL
that	NULL
is	NULL
counteracted	NULL
by	NULL
rapid	NULL
degradation	NULL
of	NULL
cytokine	NULL
mRNA	NULL
.	NULL

LPS	NULL
-	NULL
+	NULL
-o	NULL
+	NULL
LPS	NULL
-o	NULL
&	NULL
00	NULL
-	NULL
+	NULL
Anti-TNF	NULL
-o	NULL
0	NULL
-	NULL
0	NULL
+0	NULL
0+	NULL
Anti-	NULL
(	NULL
IL-6	NULL
)	NULL
-o	NULL
-	NULL
40	NULL
+	NULL
#	NULL
®	NULL
ab	NULL
8	NULL
-	NULL
20	NULL
--	NULL
6+	NULL
15	NULL
+	NULL
E	NULL
E	NULL
E	NULL
a	NULL
E	NULL
4	NULL
+	NULL
510——	NULL
&	NULL
©	NULL
-	NULL
=	NULL
!	NULL

2	NULL
1	NULL
5+	NULL
OJE	NULL
-	NULL
]	NULL
o	NULL
L	NULL
[	NULL
.	NULL

!	NULL

at..	NULL

Figure	NULL
7	NULL
-	NULL
Lack	NULL
of	NULL
effect	NULL
of	NULL
anti-TNF	NULL
and	NULL
anti-lL-6	NULL
on	NULL
constitutive	NULL
NF-xB	NULL
Mone	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
treated	NULL
overnight	NULL
with	NULL
neutralizing	NULL
antibodies	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
after	NULL
an	NULL
additional	NULL
45	NULL
min	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
recovered	NULL
4	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
and	NULL
TNF	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
Wehi-164S/actinomycin	NULL
D	NULL
cytotoxicity	NULL
assay	NULL
,	NULL
and	NULL
IL-6	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
7TD1	NULL
bioassay	NULL
(	NULL
one	NULL
of	NULL
two	NULL
experiments	NULL
each	NULL
)	NULL
.	NULL

Blockade	NULL
of	NULL
autocrine	NULL
pathways	NULL
Since	NULL
cytokines	NULL
like	NULL
TNF	NULL
are	NULL
capable	NULL
of	NULL
inducing	NULL
a	NULL
mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
one	NULL
might	NULL
speculate	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
such	NULL
autocrine	NULL
cytokines	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
have	NULL
performed	NULL
blocking	NULL
studies	NULL
in	NULL
order	NULL
to	NULL
exclude	NULL
a	NULL
role	NULL
for	NULL
monocyte-derived	NULL
cytokines	NULL
and	NULL
arachidonic	NULL
acid	NULL
metabolites	NULL
.	NULL

Treatment	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
overnight	NULL
with	NULL
anti-TNF	NULL
antibody	NULL
did	NULL
not	NULL
affect	NULL
constitutive	NULL
or	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
while	NULL
at	NULL
the	NULL
same	NULL
time	NULL
the	NULL
antibody	NULL
efficiently	NULL
neutralized	NULL
LPS-induced	NULL
TNF	NULL
activity	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
antibody	NULL
was	NULL
capable	NULL
of	NULL
inactivating	NULL
TNF	NULL
protein	NULL
that	NULL
might	NULL
be	NULL
produced	NULL
at	NULL
low	NULL
but	NULL
undetectable	NULL
levels	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

The	NULL
same	NULL
applied	NULL
to	NULL
anti-IL-6	NULL
antibody	NULL
,	NULL
which	NULL
efficiently	NULL
neutralized	NULL
IL-6	NULL
activity	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
constitutive	NULL
or	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Additional	NULL
anti-cytokine	NULL
antibodies	NULL
that	NULL
were	NULL
found	NULL
not	NULL
to	NULL
affect	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
Constitutive	NULL
nuclear	NULL
NF-B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
93	NULL
either	NULL
were	NULL
anti-	NULL
(	NULL
IL-1/	NULL
$	NULL
)	NULL
,	NULL
anti-	NULL
(	NULL
IL-10	NULL
)	NULL
,	NULL
anti-	NULL
(	NULL
M-CSF	NULL
)	NULL
and	NULL
anti-	NULL
(	NULL
GM-CSF	NULL
)	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
blockade	NULL
of	NULL
cyclo-oxygenase	NULL
and	NULL
lipoxygenase	NULL
pathways	NULL
of	NULL
arachidonic	NULL
acid	NULL
metabolism	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Hence	NULL
,	NULL
although	NULL
not	NULL
all	NULL
monocyte	NULL
products	NULL
have	NULL
been	NULL
studied	NULL
,	NULL
this	NULL
set	NULL
of	NULL
major	NULL
monocyte-derived	NULL
cytokines	NULL
and	NULL
arachidonic	NULL
acid	NULL
metabolites	NULL
can	NULL
be	NULL
excluded	NULL
as	NULL
inducers	NULL
of	NULL
constitutive	NULL
NF-kB	NULL
.	NULL

DISCUSSION	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
central	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
defence	NULL
.	NULL

The	NULL
genes	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
grouped	NULL
into	NULL
(	NULL
a	NULL
)	NULL
cytokines	NULL
,	NULL
(	NULL
b	NULL
)	NULL
receptors	NULL
and	NULL
(	NULL
c	NULL
)	NULL
acute-phase	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
some	NULL
viruses	NULL
,	NULL
like	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
cytomegalovirus	NULL
,	NULL
have	NULL
picked	NULL
up	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequences	NULL
and	NULL
exploit	NULL
this	NULL
transcription	NULL
factor	NULL
for	NULL
their	NULL
propagation	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
leucocytes	NULL
by	NULL
different	NULL
types	NULL
of	NULL
signals	NULL
will	NULL
lead	NULL
,	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
to	NULL
the	NULL
release	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
from	NULL
the	NULL
inhibitor	NULL
IxB	NULL
.	NULL

The	NULL
p50/p65	NULL
complex	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
binds	NULL
to	NULL
regulatory	NULL
sequences	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
GGGRNN-TYCC	NULL
.	NULL

Constitutive	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
without	NULL
deliberate	NULL
activation	NULL
has	NULL
been	NULL
noted	NULL
for	NULL
B	NULL
lymphocytes	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
and	NULL
more	NULL
recently	NULL
also	NULL
for	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
system	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Haas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Monocytes	NULL
are	NULL
,	NULL
however	NULL
,	NULL
very	NULL
sensitive	NULL
to	NULL
external	NULL
signals	NULL
.	NULL

Adbesion	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
can	NULL
trigger	NULL
gene	NULL
expression	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
and	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
LPS	NULL
(	NULL
in	NULL
the	NULL
pg/ml	NULL
!	NULL

range	NULL
)	NULL
may	NULL
induce	NULL
expression	NULL
of	NULL
genes	NULL
,	NULL
like	NULL
IL-6	NULL
(	NULL
Taktak	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

LPS	NULL
is	NULL
a	NULL
frequent	NULL
contaminant	NULL
of	NULL
tissue-culture	NULL
media	NULL
,	NULL
where	NULL
it	NULL
can	NULL
be	NULL
introduced	NULL
by	NULL
medium	NULL
ingredients	NULL
,	NULL
by	NULL
FCS	NULL
or	NULL
by	NULL
contaminated	NULL
glassware	NULL
(	NULL
Weinberg	NULL
,	NULL
1981	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
a	NULL
monocyte	NULL
function	NULL
considered	NULL
constitutive	NULL
is	NULL
actually	NULL
induced	NULL
by	NULL
unrecognized	NULL
signals	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
cultured	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
and	NULL
we	NULL
have	NULL
removed	NULL
LPS	NULL
by	NULL
ultrafiltration	NULL
.	NULL

With	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
could	NULL
show	NULL
that	NULL
monocytes	NULL
do	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
mobilize	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
independent	NULL
of	NULL
external	NULL
signals	NULL
.	NULL

It	NULL
was	NULL
suggested	NULL
recently	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
within	NULL
the	NULL
monocyte	NULL
lineage	NULL
may	NULL
increase	NULL
with	NULL
increasing	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
and	NULL
primary	NULL
cells	NULL
studied	NULL
herein	NULL
represent	NULL
different	NULL
stages	NULL
of	NULL
maturation	NULL
,	NULL
and	NULL
it	NULL
is	NULL
apparent	NULL
from	NULL
our	NULL
analysis	NULL
that	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
not	NULL
increase	NULL
with	NULL
differentiation	NULL
.	NULL

When	NULL
looking	NULL
at	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
,	NULL
there	NULL
appears	NULL
to	NULL
be	NULL
,	NULL
however	NULL
,	NULL
a	NULL
trend	NULL
to	NULL
higher	NULL
levels	NULL
of	NULL
inducible	NULL
NF-KB	NULL
in	NULL
the	NULL
more	NULL
mature	NULL
cells	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
higher	NULL
levels	NULL
of	NULL
'constitutive	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
under	NULL
conditions	NULL
of	NULL
inadvertant	NULL
activation	NULL
.	NULL

This	NULL
may	NULL
have	NULL
been	NULL
the	NULL
case	NULL
in	NULL
studies	NULL
by	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
these	NULL
investigators	NULL
employed	NULL
different	NULL
sublines	NULL
of	NULL
the	NULL
original	NULL
cell	NULL
lines	NULL
.	NULL

Autocrine	NULL
mechanisms	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
maintaining	NULL
the	NULL
constitutive	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
since	NULL
monocyte-derived	NULL
cytokines	NULL
like	NULL
TNF	NULL
are	NULL
efficient	NULL
inducers	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

By	NULL
using	NULL
neutralizing	NULL
antibodies	NULL
against	NULL
this	NULL
and	NULL
several	NULL
other	NULL
cytokines	NULL
and	NULL
by	NULL
using	NULL
blockade	NULL
of	NULL
arachidonic	NULL
acid	NULL
metabolism	NULL
,	NULL
we	NULL
were	NULL
,	NULL
however	NULL
,	NULL
unable	NULL
to	NULL
remove	NULL
or	NULL
reduce	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Hence	NULL
,	NULL
an	NULL
autocrine	NULL
mechanism	NULL
can	NULL
be	NULL
excluded	NULL
with	NULL
regard	NULL
to	NULL
these	NULL
major	NULL
monocytic	NULL
products	NULL
.	NULL

The	NULL
question	NULL
remains	NULL
what	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
such	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
might	NULL
be	NULL
:	NULL
in	NULL
other	NULL
studies	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
mainly	NULL
consists	NULL
of	NULL
p50	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
may	NULL
be	NULL
related	NULL
to	NULL
the	NULL
nuclear	NULL
factor	NULL
KBF1	NULL
,	NULL
which	NULL
was	NULL
described	NULL
to	NULL
regulate	NULL
MHC	NULL
class	NULL
I	NULL
expression	NULL
(	NULL
Israel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
affinity	NULL
cross-linking	NULL
of	NULL
a	NULL
similar	NULL
high-mobility	NULL
band	NULL
in	NULL
uninduced	NULL
U937	NULL
cells	NULL
demonstrates	NULL
a	NULL
p50	NULL
and	NULL
a	NULL
p55	NULL
band	NULL
within	NULL
this	NULL
complex	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

As	NULL
to	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
monocytes	NULL
,	NULL
we	NULL
do	NULL
see	NULL
significant	NULL
cytokine	NULL
expression	NULL
in	NULL
untreated	NULL
monocytic	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
no	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
evidence	NULL
linking	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
constitutive	NULL
TNF	NULL
is	NULL
,	NULL
however	NULL
,	NULL
only	NULL
circumstantial	NULL
.	NULL

To	NULL
resolve	NULL
this	NULL
question	NULL
,	NULL
studies	NULL
with	NULL
stable	NULL
reporter	NULL
gene	NULL
transfectants	NULL
are	NULL
required	NULL
.	NULL

Constitutive	NULL
TNF	NULL
transcripts	NULL
were	NULL
also	NULL
reported	NULL
to	NULL
occur	NULL
in	NULL
various	NULL
human	NULL
tissues	NULL
(	NULL
Tovey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
and	NULL
one	NULL
might	NULL
speculate	NULL
that	NULL
tissue	NULL
macrophages	NULL
are	NULL
the	NULL
source	NULL
of	NULL
such	NULL
cytokine	NULL
mRNA	NULL
.	NULL

Furthermore	NULL
,	NULL
whole	NULL
blood	NULL
cultures	NULL
blocked	NULL
in	NULL
transcription	NULL
by	NULL
actinomycin	NULL
D	NULL
could	NULL
still	NULL
be	NULL
triggered	NULL
by	NULL
LPS	NULL
to	NULL
release	NULL
TNF	NULL
protein	NULL
(	NULL
Hofsli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
preformed	NULL
TNF	NULL
transcripts	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Our	NULL
studies	NULL
in	NULL
vitro	NULL
show	NULL
that	NULL
blocking	NULL
of	NULL
mRNA	NULL
degradation	NULL
by	NULL
cycloheximide	NULL
enhances	NULL
TNF	NULL
transcript	NULL
levels	NULL
,	NULL
while	NULL
no	NULL
NF-KB	NULL
is	NULL
induced	NULL
.	NULL

Others	NULL
have	NULL
reported	NULL
that	NULL
cycloheximide	NULL
does	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Collart	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
contrasting	NULL
findings	NULL
may	NULL
be	NULL
due	NULL
to	NULL
an	NULL
LPS	NULL
contamination	NULL
of	NULL
cycloheximide	NULL
or	NULL
to	NULL
the	NULL
use	NULL
of	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
the	NULL
enhancement	NULL
of	NULL
TNF	NULL
transcripts	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
cycloheximide	NULL
effect	NULL
on	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
our	NULL
study	NULL
argues	NULL
that	NULL
cycloheximide	NULL
may	NULL
simply	NULL
prevent	NULL
the	NULL
degradation	NULL
of	NULL
constitutively	NULL
transcribed	NULL
TNF	NULL
mRNA	NULL
.	NULL

Such	NULL
an	NULL
ongoing	NULL
transcription	NULL
,	NULL
probably	NULL
driven	NULL
by	NULL
constitutive	NULL
NF-KB	NULL
,	NULL
may	NULL
allow	NULL
monocytes	NULL
to	NULL
react	NULL
extremely	NULL
rapidly	NULL
to	NULL
external	NULL
stimuli	NULL
like	NULL
invading	NULL
micro-organisms	NULL
.	NULL

REFERENCES	NULL
P.	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
Blumenstein	NULL
,	NULL
M.	NULL
,	NULL
Schmidt	NULL
,	NULL
B.	NULL
,	NULL
Ward	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
and	NULL
Gurland	NULL
,	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nephron	NULL
50	NULL
,	NULL
277-281	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Bauerle	NULL
,	NULL
P.	NULL
and	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1506	NULL
Collins	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
and	NULL
Gallagher	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1977	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
270	NULL
,	NULL
347-349	NULL
Dugaiczyk	NULL
,	NULL
A.	NULL
,	NULL
Haron	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Stone	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Dennison	NULL
,	NULL
0	NULL
.	NULL

E.	NULL
,	NULL
Rothblum	NULL
,	NULL
K.	NULL
N.	NULL
and	NULL
Schwartz	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Biochemistry	NULL
22	NULL
,	NULL
1605-1613	NULL
Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
339	NULL
,	NULL
70-73	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Bduerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
and	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
87	NULL
,	NULL
9563-9567	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Johnson	NULL
,	NULL
C.	NULL
,	NULL
Eierman	NULL
,	NULL
D.	NULL
,	NULL
Becker	NULL
,	NULL
S.	NULL
and	NULL
Warren	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
1690-1694	NULL
Hofsli	NULL
,	NULL
E.	NULL
,	NULL
Lamvik	NULL
,	NULL
J.	NULL
and	NULL
Nissen-Meyer	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
435-441	NULL
Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
BGhnlein	NULL
,	NULL
E.	NULL
,	NULL
Sigkevitz	NULL
,	NULL
M.	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
Israel	NULL
,	NULL
A.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
0.	NULL
,	NULL
Hatat	NULL
,	NULL
D.	NULL
,	NULL
Piette	NULL
,	NULL
J.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Wallach	NULL
,	NULL
D.	NULL
,	NULL
Fellous	NULL
,	NULL
M.	NULL
and	NULL
Kouriisky	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3793-3800	NULL
Kaufman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Weinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
121-129	NULL
Liebermann	NULL
,	NULL
T.	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
Lozzio	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Lozzio	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Yang	NULL
,	NULL
W.-K.	NULL
,	NULL
Ichiki	NULL
,	NULL
A.	NULL
T.	NULL
and	NULL
Bamberger	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1976	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

36	NULL
,	NULL
4657-4662	NULL
Minowada	NULL
,	NULL
J.	NULL
,	NULL
Ohnuma	NULL
,	NULL
T.	NULL
and	NULL
Moore	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1972	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

49	NULL
,	NULL
891-895	NULL
Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
and	NULL
Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunobiology	NULL
187	NULL
,	NULL
233-256	NULL
Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Naylor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sakaguchi	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
,	NULL
Jarrett-Nedwin	NULL
,	NULL
J.	NULL
,	NULL
Pennica	NULL
,	NULL
D.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
and	NULL
Gray	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13	NULL
,	NULL
6361-6373	NULL
Sen	NULL
,	NULL
R.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
and	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
Sundstrém	NULL
,	NULL
C.	NULL
K.	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
(	NULL
1976	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
17	NULL
,	NULL
565-577	NULL
Taktak	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
Selkirk	NULL
,	NULL
S.	NULL
,	NULL
Bristow	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Carpenter	NULL
,	NULL
A.	NULL
,	NULL
Ball	NULL
,	NULL
C.	NULL
,	NULL
Rafferty	NULL
,	NULL
B.	NULL
and	NULL
Poole	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Pharm	NULL
.	NULL

Pharmacol	NULL
.	NULL

43	NULL
,	NULL
578-582	NULL
Tovey	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Content	NULL
,	NULL
J.	NULL
,	NULL
Gresser	NULL
,	NULL
I.	NULL
,	NULL
Gugenheim	NULL
,	NULL
J.	NULL
,	NULL
Blanchard	NULL
,	NULL
B.	NULL
,	NULL
Buymarho	NULL
,	NULL
J.	NULL
,	NULL
Poupart	NULL
,	NULL
P.	NULL
,	NULL
Gigou	NULL
,	NULL
M.	NULL
,	NULL
Shaw	NULL
,	NULL
A.	NULL
and	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
141	NULL
,	NULL
3106-3110	NULL
Tsuchiya	NULL
,	NULL
M.	NULL
,	NULL
Yamabe	NULL
,	NULL
M.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
Y.	NULL
,	NULL
Kobayashi	NULL
,	NULL
Y.	NULL
,	NULL
Konno	NULL
,	NULL
K.	NULL
and	NULL
Tada	NULL
,	NULL
K.	NULL
(	NULL
1980	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
26	NULL
,	NULL
171-176	NULL
van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
Cayphas	NULL
,	NULL
S.	NULL
,	NULL
Vink	NULL
,	NULL
A.	NULL
,	NULL
Uyttenhove	NULL
,	NULL
C.	NULL
,	NULL
Coulie	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rubira	NULL
,	NULL
M.	NULL
R.	NULL
and	NULL
Simpson	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
83	NULL
,	NULL
9679-9683	NULL
94	NULL
M.	NULL
Frankenberger	NULL
and	NULL
others	NULL
Weinberg	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
in	NULL
Methods	NULL
for	NULL
Studying	NULL
Mononuclear	NULL
Phagocytes	NULL
,	NULL
pp	NULL
.	NULL

139-154	NULL
,	NULL
Academic	NULL
Press	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Miller	NULL
,	NULL
A.	NULL
,	NULL
Linke	NULL
,	NULL
R.	NULL
P.	NULL
L.	NULL
,	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Rigber	NULL
,	NULL
E.	NULL
P.	NULL
and	NULL
Riethmillier	NULL
,	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

46	NULL
,	NULL
5947-5952	NULL
Ziegier-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Filtterer	NULL
,	NULL
A.	NULL
,	NULL
Herzog	NULL
,	NULL
V.	NULL
,	NULL
Wirtz	NULL
,	NULL
A.	NULL
and	NULL
Riethmiilier	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
41	NULL
,	NULL
456-461	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Blumenstein	NULL
,	NULL
M.	NULL
,	NULL
Kifferlein	NULL
,	NULL
E.	NULL
,	NULL
Kieper	NULL
,	NULL
D.	NULL
,	NULL
Petersmann	NULL
,	NULL
I.	NULL
,	NULL
Received	NULL
7	NULL
March	NULL
1994/23	NULL
May	NULL
1994	NULL
;	NULL
accepted	NULL
21	NULL
June	NULL
1994	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
.	NULL

Flegel	NULL
,	NULL
W.	NULL
,	NULL
Northoff	NULL
,	NULL
H.	NULL
and	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Immunology	NULL
75	NULL
,	NULL
264-268	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Sternsdort	NULL
,	NULL
T.	NULL
,	NULL
Liese	NULL
,	NULL
J.	NULL
,	NULL
Belohradsky	NULL
,	NULL
B.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Bduerie	NULL
,	NULL
P.	NULL
and	NULL
Strdbel	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6986-6993	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schraut	NULL
,	NULL
W.	NULL
,	NULL
Strobel	NULL
,	NULL
M.	NULL
,	NULL
WendelgaB	NULL
,	NULL
P.	NULL
,	NULL
Stemsdort	NULL
,	NULL
T.	NULL
,	NULL
Bduerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
and	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
17001-17004	NULL

